Updated:
Blue Water Acquisition Corp. III
Blue Water Acquisition Corp. III is a blank-check company that raised $57.5M in its 2021 IPO to acquire a life sciences business.
Blue Water Acquisition Corp. III
Blue Water Acquisition Corp. III was incorporated as a blank-check company, structured as a special-purpose acquisition company (SPAC). It priced its initial public offering on August 6, 2021, raising gross proceeds of $57.5 million by selling 5.75 million units at $10.00 per unit (per SEC filings, August 2021). Each unit consisted of one share of Class A common stock and one redeemable warrant. The company listed on the Nasdaq Global Market under the ticker symbol BLUW. The sponsor entity, Blue Water Sponsor LLC, held founder shares and warrants aligned with standard SPAC promoter economics. The SPAC's stated mandate was to identify and merge with a business operating in the life sciences, medical devices, or healthcare technology sectors. It did not limit its search geographically, but the management team's background suggested a focus on North American and European targets. The trust account, holding IPO proceeds plus underwriter over-allotment funds, was invested in U.S. government securities pending a business combination. SPACs of this vintage operated under a typical 18-to-24-month deadline to complete a deal, facing mandatory liquidation and return of trust proceeds to public shareholders if no merger was consummated. Blue Water Acquisition Corp. III represented the third iteration of a serial SPAC sponsor group. The management team and board drew from operating, investing, and transactional experience, a common pattern among repeat SPAC issuers of the 2020–2021 wave. In September 2022, the company extended its initial deadline to complete a business combination through a series of charter amendments, a frequent tactic among SPACs struggling to find or close a target during the post-2021 market downturn (per SEC filings, September 2022). These extensions involved sponsor contributions to the trust account to fund additional time. Structurally, Blue Water III operated as a pure-deal vehicle rather than an operating company. The key differentiator among serial SPAC sponsors is whether they can consummate a value-accretive merger when market conditions deteriorate. Many sponsors that raised funds during the 2021 bubble — particularly sub-$100 million SPACs — have since liquidated and returned capital. The repeated charter extensions signal a sponsor attempting to avoid liquidation in a hostile environment for de-SPAC transactions.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Frequently asked questions
What happened to Blue Water Acquisition Corp. III after its IPO?
Following its $57.5 million IPO in August 2021, the SPAC searched for a life sciences acquisition target but did not announce a definitive merger agreement. By September 2022, it had extended its business combination deadline multiple times, a process that required the sponsor to deposit additional funds into the trust account. The ultimate outcome — whether it completed a merger or liquidated — requires checking the most recent SEC filings for the company.
What sector was Blue Water Acquisition Corp. III targeting for a merger?
The SPAC's registration statement identified the life sciences, medical devices, and healthcare technology sectors as its primary focus. These areas represented a broad mandate encompassing biotech, diagnostics, tools, digital health, and related healthcare verticals, without committing to a specific subsector or stage of company maturity.
Who were the principals behind Blue Water Acquisition Corp. III?
The SPAC was sponsored by an affiliate of a serial sponsor group that had launched prior Blue Water vehicles. The specific named officers and directors were disclosed in the SEC registration statement and are matters of public record with the SEC, but the small size of the offering and subsequent lack of a completed deal have resulted in limited institutional coverage of the individual principals.
How is a SPAC like Blue Water III different from an operating company investment?
As a blank-check company, Blue Water Acquisition Corp. III had no operations at the time of its IPO. Its sole purpose was to act as a publicly traded pool of capital that would merge with a private operating company, thereby taking that target public. Until a merger closed, its assets consisted only of the IPO proceeds held in trust. Investing in such a vehicle meant underwriting both the sponsor's ability to find a suitable target and the target company's standalone fundamentals.
Why would a SPAC extend its merger deadline beyond the initial two-year window?
Charter amendments to extend the deadline are common when sponsors have not yet found or closed a deal but believe one remains possible. To secure an extension, the sponsor typically contributes cash to the trust account as consideration. This tactic grew widespread during 2022 and 2023 as many 2021-vintage SPACs faced a deteriorating market for de-SPAC mergers, rising redemptions, and difficulties securing PIPE financing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: